NDC 4422-0017 - Model 2004FAA Model 3-EEMK Model 3-EEMK-1 Model AA-8565 Model AA-8565-LATAM Model AWFAREMK Model CHAUTAUQUAEMK Model emk1000-10 Model FAREMK Model PMONTFAREMK Model SWEEMK Model SWEEMK-1 Model QXEMK Model G4FAREMK Model AA-8565 (excluding Miami Air)
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 4422-0017
- Manufacturer
- Aerospace Accessory Service, Inc
- Effective date
- 2021-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sodium Chloride - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 8c63be55-5de4-7f72-e053-2995a90a102e | 2024-01-30 | Warnings, Adverse reactions | 1737761 V13007Z41A |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | c0d1def8-9f47-0d3e-e053-2995a90af955 | 2024-01-30 | Warnings, Adverse reactions | NDA209359 727373 YKH834O4BH |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999dd95d-87fe-12c0-e053-2995a90aa9f7 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4bf5905-add7-1cb0-e053-2995a90a7334 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4c0df51-cc37-323d-e053-2995a90a154a | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 7a664a34-19fd-4a7b-ab4d-11299b32999e | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | fd6343a9-15a6-4894-b51f-122e4d6dbe79 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Seton Pharmaceuticals LLC | 3c5cefe3-c84e-4380-97f3-78e3fe92543a | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Seton Pharmaceuticals | 1c0abe84-5404-404e-b882-e910e4d43ffb | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 951862db-3a73-4d25-9d5b-e4111833f43b | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| ATOMY DERMA CALMING SUN | TITANIUM DIOXIDE | ATOMY CO., LTD. | fd5fc3ba-6e7c-4e48-8e65-47c03141df45 | 2024-01-30 | Warnings | 15FIX9V2JP |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 6aa284d6-0212-4fb5-809d-c721aa6fe2ba | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Kroger Nighttime Sleep Aid CAPLET | DIPHENHYDRAMINE HYDROCHLORIDE | The Kroger Co. | f0f3f58d-9457-4697-98e6-ef52d350cf67 | 2024-01-29 | Warnings | 1049630 TC2D6JAD40 |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | NDA017584 1737761 V13007Z41A |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Haleon US Holdings LLC | 61802b27-c9ec-4386-9d44-45e8b1e558b7 | 2024-01-28 | Warnings | R16CO5Y76E 362O9ITL9D |
| Theraflu Daytime Severe Cold and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE | Haleon US Holdings LLC | c0689223-5c90-4dbc-bbfa-f94e267504c3 | 2024-01-28 | Warnings | 362O9ITL9D |
| Excedrin Migraine Geltabs | ACETAMINOPHEN, ASPRIN, CAFFEINE | Haleon US Holdings LLC | cc2f4a6f-2a27-4a60-b5ef-ae0bb0988ff8 | 2024-01-28 | Warnings | R16CO5Y76E 362O9ITL9D |
| THERAFLU MULTI-SYMPTOM SEVERE COLD | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Haleon US Holdings LLC | a4c56ca0-7785-404b-996d-137cc135f270 | 2024-01-28 | Warnings | 362O9ITL9D |
| THERAFLU NIGHTTIME SEVERE COLD AND COUGH | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Haleon US Holdings LLC | 5f7f6f70-0f36-4541-89f2-d953259cdb1e | 2024-01-28 | Warnings | TC2D6JAD40 362O9ITL9D |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 0060b971-19bd-2849-e063-6294a90afca8 | 2024-01-28 | Warnings, Adverse reactions | 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.